Oral Probiotic Supplementation in Pregnancy to Reduce Group B Streptococcus Colonisation (OPSiP trial): study protocol for a double-blind parallel group randomised placebo trial

Introduction Group B streptococcus (GBS), or Streptococcus agalactiae, remains a leading cause of neonatal morbidity and mortality. Canadian guidelines advise universal maternal screening for GBS colonisation in pregnancy in conjunction with selective antibiotic therapy. This results in over 1000 pr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Beth A Payne, Patricia Johnson, Patricia Janssen, Michelle Butler, Kelly Hayes, Cecilia Jevitt, Will Johnston
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2024-02-01
Col·lecció:	BMJ Open
Accés en línia:	https://bmjopen.bmj.com/content/14/2/e076455.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!